Probiotik sebagai Pencegahan Reinfeksi Pasien dengan Antibiotic Associated Diarrhea
DOI:
https://doi.org/10.55175/cdk.v47i9.569Kata Kunci:
Antibiotic Associated Diarrhea, infeksi Clostridium difficile, pencegahan, probiotikAbstrak
Latar Belakang: Diare akut sering ditemukan dalam praktik klinis sehari-hari. Probiotik diketahui dapat meningkatkan imunitas lokal dan mempercepat waktu penyembuhan diare. Saat ini belum ada pedoman terkait pemberian probiotik sebagai pencegahan reinfeksi C. difficile pada pasien dewasa dengan Antibiotic Associated Diarrhea. Tujuan: Mengetahui efektivitas probiotik dalam mencegah reinfeksi Clostridium difficile. Metode: Penelurusan literatur dari database PubMed, Clinical Key, Science Direct, dan Proquest. Telaah kritis menggunakan appraisal sheet untuk systematic review dari Oxford Center for Evidence Based Medicine tahun 2011. Hasil: Didapatkan 2 studi meta-analisis dengan validitas baik. Goldenberg, et al, menunjukkan penggunaan probiotik dalam mencegah infeksi C. difficile dengan RR 0,62 (95% CI 0,30–0,52) dengan NNT 22. Shen, et al, mendapatkan RR 0,42 (95% CI: 0,3-0,5; p < 0,001) dengan NNT 1,757. Simpulan: Probiotik berpotensi mencegah reinfeksi Clostridium difficile.
Background: Acute diarrhea is a common disease in clinical practice. Probiotics are known to increase local immunity and reduce length of healing among diarrhea patients. Currently there are no guidelines related to the administration of probiotics as prevention of C. difficile reinfection in adult patients with antibiotic associated diarrhea. Objective: To determine the effectiveness of probiotics in preventing Clostridium difficile reinfection. Method: Literature searching through database, such as PubMed, Clinical Key, Science Direct, and Proquest. A critical review used appraisal sheet for systematic review from Oxford Center for Evidence Based Medicine in 2011. Result: Two meta-analysis studies with good validity. Goldenberg, et al, demonstrated the use of probiotics in the prevention of C. difficile infection with RR 0.62 (95% CI 0.30-0.52) and NNT 22. On the other hand, Shen, et al, obtained RR 0.42 (95 % CI: 0.3-0.5; p <0.001) with NNT 1.757. Conclusion: Probiotics have the potential to prevent Clostridium difficile reinfection.
Unduhan
Referensi
Simadibrata M, Daldiyono. Diare akut, In: Sudoyono AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, eds. Buku ajar ilmu penyakit dalam. Jakarta: Interna Publishing; 2010
Leon TD. Acute diarrhea. In: Kellerman R, Bope, Edward T, eds. Conn’s current therapy. Pennsylvania: Saunders; 2018
Chen LA, Sears CL. Prebiotics, probiotics and synbiotics. In: Bennett J, Dolin R, Blaser M, eds. Mandell, Douglas, and Bennett's principles and practice of infectious disease. Pennsylvania: Saunders Elsevier; 2015.
Guarino A, Guandalini S, Lo Vecchio A. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2015;49:37-45.
Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients - a systematic review and meta-analysis. Antibiotics.2017;6(21):1-17.
Chakra CNA, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications, and mortality in Clostridium difficile infection: A systematic review. PloS One. 2014;9(6):e98400.
Goldenberg JZ, Yap C, Lytvyn L, Lo CKF, Beardsley J, Mertz D, et al. Probiotics for the prevention of Clostridium difficile associated diarrhea in adults and children. Cochrane Database of Syst Rev. 2017;12:CD006095.
Shen NT, Maw A, Tmanova LL, Pino A, Ancy K, Carl V, et al. Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: A systematic review with meta-regression analysis. Gastroenterol. 2017;152:1889–900.
US Department of Health and Human Services, National Institutes of Health. National Center for Complementary and Integrative Health (NCCIH). Probiotics: What you need to know [Internet]. [cited 2020 March 4]. Available from: https://nccih.nih.gov/health/probiotics/introduction.htm#hed3.
McFarland LV. From yaks to yogurt: The history, development, and current use of probiotics. Clin Infect Dis. 2015;60(Suppl 2):85–90
Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: A systematic review and meta-analysis. Ann Intern Med 2012;157:878–88.
Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2013;382:1249–57.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2020 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
